The validity of previously sex‐specific cut‐offs of ALT (26 IU/L in boys and 22 IU/L in girls) in children with NAFLD is confirmed also in youths with OW/OB and MASLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.